HC Wainwright Initiates Coverage on Phio Pharmaceuticals (NASDAQ:PHIO)
Research analysts at HC Wainwright initiated coverage on shares of Phio Pharmaceuticals (NASDAQ:PHIO – Get Free Report) in a research note issued on Thursday, Marketbeat.com reports. The brokerage set a “buy” rating and a $14.00 price target on the stock. HC Wainwright’s price target would indicate a potential upside of 372.97% from the stock’s previous […]
Research analysts at HC Wainwright initiated coverage on shares of Phio Pharmaceuticals (NASDAQ:PHIO – Get Free Report) in a research note issued on Thursday, Marketbeat.com reports. The brokerage set a “buy” rating and a $14.00 price target on the stock. HC Wainwright’s price target would indicate a potential upside of 372.97% from the stock’s previous […]
